| 0 |
Topoisomerase Inhibitor [EPC] |
37 |
0.0005 |
| 1 |
Human Immunoglobulin G [EPC] |
3 |
0.0001 |
| 2 |
Platinum-based Drug [EPC] |
38 |
0.0001 |
| 3 |
Typical Antipsychotic [EPC] |
2 |
0.0001 |
| 4 |
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
1 |
0.0001 |
| 5 |
Nonergot Dopamine Agonist [EPC] |
1 |
0.0001 |
| 6 |
Integrin Receptor Antagonist [EPC] |
4 |
0.0000 |
| 7 |
Alkylating Drug [EPC] |
10 |
0.0000 |
| 8 |
Iron Chelator [EPC] |
1 |
0.0000 |
| 9 |
Provitamin D2 Compound [EPC] |
1 |
0.0000 |
| 10 |
Proteasome Inhibitor [EPC] |
2 |
0.0000 |
| 11 |
CD20-directed Cytolytic Antibody [EPC] |
5 |
0.0000 |
| 12 |
Interleukin-6 Receptor Antagonist [EPC] |
2 |
0.0000 |
| 13 |
HER2/neu Receptor Antagonist [EPC] |
1 |
0.0000 |
| 14 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
1 |
0.0000 |
| 15 |
Estrogen [EPC] |
2 |
0.0000 |
| 16 |
Purine Antimetabolite [EPC] |
1 |
0.0000 |
| 17 |
Aminosalicylate [EPC] |
1 |
0.0000 |
| 18 |
Interleukin-23 Antagonist [EPC] |
1 |
0.0000 |
| 19 |
Microtubule Inhibitor [EPC] |
1 |
0.0000 |
| 20 |
Corticosteroid [EPC] |
7 |
0.0000 |
| 21 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 22 |
Retinoid [EPC] |
1 |
0.0000 |
| 23 |
Tumor Necrosis Factor Blocker [EPC] |
4 |
0.0000 |
| 24 |
Progestin [EPC] |
1 |
0.0000 |
| 25 |
Vitamin D [EPC] |
1 |
0.0000 |
| 26 |
Vitamin B12 [EPC] |
1 |
0.0000 |
| 27 |
Dihydropyridine Calcium Channel Blocker [EPC] |
1 |
0.0000 |
| 28 |
Benzodiazepine [EPC] |
2 |
0.0000 |
| 29 |
HMG-CoA Reductase Inhibitor [EPC] |
1 |
0.0000 |
| 30 |
Vitamin C [EPC] |
1 |
0.0000 |
| 31 |
Atypical Antipsychotic [EPC] |
1 |
0.0000 |
| 32 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
1 |
0.0000 |
| 33 |
Proton Pump Inhibitor [EPC] |
1 |
0.0000 |
| 34 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
1 |
0.0000 |